ADP-ribosyl cyclase as a therapeutic target for central nervous system diseases

Alla B. Salmina, Raissa Ya Olovyannikova, Mami Noda, Haruhiro Higashida

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

NAD+ is as abundant as ATP in neuronal cells. NAD+ functions not only as a coenzyme but also as a substrate. NAD+ metabolism in neuronal cells is tightly controlled under physiological conditions, since NAD+ has a great impact on functional activity of neurons upon stimulation. NAD+-utilizing enzymes is involved in signal transduction. We focus on ADP-ribosyl cyclase/CD38 which synthesizes cyclic ADP-ribose (cADPR), a Ca2+ mobilizing messenger. Structural analysis defined the active site of the enzyme. ADP-ribosyl cyclase associated with CD38 was detected in the central nervous system (CNS) where its activity and expression were developmentally regulated. CD38 has been reported to have different subcellular locations either in neurons or in glial cells, suggesting multiple roles. cADPR, acts as a universal calcium mobilizer from intracellular stores independently from inositol trisphosphate which acts through activation/modulation of ryanodine receptor channels involving FKBP12.6. cADPR was also involved in the regulation of some potassium currents in synaptic activity. cADPR synthesis in neuronal cells is stimulated or modulated via different pathways and various factors. Subtype-specific coupling of various neurotransmitter receptors with ADP-ribosyl cyclase confirms the involvement of the enzyme in signal transduction in neurons and glial cells. Therefore, it is possible that pharmacological manipulation of intracellular cADPR levels through ADP-ribosyl cyclase activity or expression, in the CNS may provide new therapeutic opportunities for treatment of neurological disorders.

Original languageEnglish
Pages (from-to)193-210
Number of pages18
JournalCentral Nervous System Agents in Medicinal Chemistry
Volume6
Issue number3
DOIs
Publication statusPublished - Oct 6 2006

Fingerprint

ADP-ribosyl Cyclase
Cyclic ADP-Ribose
Central Nervous System Diseases
NAD
Neurons
Neuroglia
Signal Transduction
Enzymes
Central Nervous System
Therapeutics
Ryanodine Receptor Calcium Release Channel
Neurotransmitter Receptor
Coenzymes
Inositol
Nervous System Diseases
Catalytic Domain
Potassium
Adenosine Triphosphate
Pharmacology
Calcium

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Neuropsychology and Physiological Psychology
  • Molecular Medicine

Cite this

ADP-ribosyl cyclase as a therapeutic target for central nervous system diseases. / Salmina, Alla B.; Olovyannikova, Raissa Ya; Noda, Mami; Higashida, Haruhiro.

In: Central Nervous System Agents in Medicinal Chemistry, Vol. 6, No. 3, 06.10.2006, p. 193-210.

Research output: Contribution to journalReview article

Salmina, Alla B. ; Olovyannikova, Raissa Ya ; Noda, Mami ; Higashida, Haruhiro. / ADP-ribosyl cyclase as a therapeutic target for central nervous system diseases. In: Central Nervous System Agents in Medicinal Chemistry. 2006 ; Vol. 6, No. 3. pp. 193-210.
@article{fb6aa96721064c8594ddf80c8a24843b,
title = "ADP-ribosyl cyclase as a therapeutic target for central nervous system diseases",
abstract = "NAD+ is as abundant as ATP in neuronal cells. NAD+ functions not only as a coenzyme but also as a substrate. NAD+ metabolism in neuronal cells is tightly controlled under physiological conditions, since NAD+ has a great impact on functional activity of neurons upon stimulation. NAD+-utilizing enzymes is involved in signal transduction. We focus on ADP-ribosyl cyclase/CD38 which synthesizes cyclic ADP-ribose (cADPR), a Ca2+ mobilizing messenger. Structural analysis defined the active site of the enzyme. ADP-ribosyl cyclase associated with CD38 was detected in the central nervous system (CNS) where its activity and expression were developmentally regulated. CD38 has been reported to have different subcellular locations either in neurons or in glial cells, suggesting multiple roles. cADPR, acts as a universal calcium mobilizer from intracellular stores independently from inositol trisphosphate which acts through activation/modulation of ryanodine receptor channels involving FKBP12.6. cADPR was also involved in the regulation of some potassium currents in synaptic activity. cADPR synthesis in neuronal cells is stimulated or modulated via different pathways and various factors. Subtype-specific coupling of various neurotransmitter receptors with ADP-ribosyl cyclase confirms the involvement of the enzyme in signal transduction in neurons and glial cells. Therefore, it is possible that pharmacological manipulation of intracellular cADPR levels through ADP-ribosyl cyclase activity or expression, in the CNS may provide new therapeutic opportunities for treatment of neurological disorders.",
author = "Salmina, {Alla B.} and Olovyannikova, {Raissa Ya} and Mami Noda and Haruhiro Higashida",
year = "2006",
month = "10",
day = "6",
doi = "10.2174/187152406778226699",
language = "English",
volume = "6",
pages = "193--210",
journal = "Central Nervous System Agents in Medicinal Chemistry",
issn = "1871-5249",
publisher = "Bentham Science Publishers B.V.",
number = "3",

}

TY - JOUR

T1 - ADP-ribosyl cyclase as a therapeutic target for central nervous system diseases

AU - Salmina, Alla B.

AU - Olovyannikova, Raissa Ya

AU - Noda, Mami

AU - Higashida, Haruhiro

PY - 2006/10/6

Y1 - 2006/10/6

N2 - NAD+ is as abundant as ATP in neuronal cells. NAD+ functions not only as a coenzyme but also as a substrate. NAD+ metabolism in neuronal cells is tightly controlled under physiological conditions, since NAD+ has a great impact on functional activity of neurons upon stimulation. NAD+-utilizing enzymes is involved in signal transduction. We focus on ADP-ribosyl cyclase/CD38 which synthesizes cyclic ADP-ribose (cADPR), a Ca2+ mobilizing messenger. Structural analysis defined the active site of the enzyme. ADP-ribosyl cyclase associated with CD38 was detected in the central nervous system (CNS) where its activity and expression were developmentally regulated. CD38 has been reported to have different subcellular locations either in neurons or in glial cells, suggesting multiple roles. cADPR, acts as a universal calcium mobilizer from intracellular stores independently from inositol trisphosphate which acts through activation/modulation of ryanodine receptor channels involving FKBP12.6. cADPR was also involved in the regulation of some potassium currents in synaptic activity. cADPR synthesis in neuronal cells is stimulated or modulated via different pathways and various factors. Subtype-specific coupling of various neurotransmitter receptors with ADP-ribosyl cyclase confirms the involvement of the enzyme in signal transduction in neurons and glial cells. Therefore, it is possible that pharmacological manipulation of intracellular cADPR levels through ADP-ribosyl cyclase activity or expression, in the CNS may provide new therapeutic opportunities for treatment of neurological disorders.

AB - NAD+ is as abundant as ATP in neuronal cells. NAD+ functions not only as a coenzyme but also as a substrate. NAD+ metabolism in neuronal cells is tightly controlled under physiological conditions, since NAD+ has a great impact on functional activity of neurons upon stimulation. NAD+-utilizing enzymes is involved in signal transduction. We focus on ADP-ribosyl cyclase/CD38 which synthesizes cyclic ADP-ribose (cADPR), a Ca2+ mobilizing messenger. Structural analysis defined the active site of the enzyme. ADP-ribosyl cyclase associated with CD38 was detected in the central nervous system (CNS) where its activity and expression were developmentally regulated. CD38 has been reported to have different subcellular locations either in neurons or in glial cells, suggesting multiple roles. cADPR, acts as a universal calcium mobilizer from intracellular stores independently from inositol trisphosphate which acts through activation/modulation of ryanodine receptor channels involving FKBP12.6. cADPR was also involved in the regulation of some potassium currents in synaptic activity. cADPR synthesis in neuronal cells is stimulated or modulated via different pathways and various factors. Subtype-specific coupling of various neurotransmitter receptors with ADP-ribosyl cyclase confirms the involvement of the enzyme in signal transduction in neurons and glial cells. Therefore, it is possible that pharmacological manipulation of intracellular cADPR levels through ADP-ribosyl cyclase activity or expression, in the CNS may provide new therapeutic opportunities for treatment of neurological disorders.

UR - http://www.scopus.com/inward/record.url?scp=33749244616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749244616&partnerID=8YFLogxK

U2 - 10.2174/187152406778226699

DO - 10.2174/187152406778226699

M3 - Review article

AN - SCOPUS:33749244616

VL - 6

SP - 193

EP - 210

JO - Central Nervous System Agents in Medicinal Chemistry

JF - Central Nervous System Agents in Medicinal Chemistry

SN - 1871-5249

IS - 3

ER -